To Demonstrate Equivalent Pharmacokinetic Properties of HD204 and Bevacizumab (Avastin®) in Healthy Male Subjects
Clinical trial NCT03390673 · COMPLETED
Trial details
- NCT number
- NCT03390673
- Sponsor
- Prestige Biopharma Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-19
- Primary completion
- 2019-03-13
- Enrollment
- 119
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.